Skip to main content
Capillary Technologies India Limited logo

Capillary Technologies India Limited — Investor Relations & Filings

Ticker · CAPILLARY ISIN · INE0ILV01024 LEI · 254900B75ZVU9SWXPI02 BSE.NS Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 119 across all filing types
Latest filing 2026-02-26 Capital/Financing Update
Country IN India
Listing BSE.NS CAPILLARY

About Capillary Technologies India Limited

https://www.capillarytech.com/

Capillary Technologies India Limited is a global software-as-a-service (SaaS) provider specializing in customer loyalty management and omnichannel engagement solutions. The company offers an integrated platform designed to help consumer brands acquire, engage, and retain customers through data-driven insights and personalized experiences. Its core product suite includes Loyalty+, an end-to-end loyalty program management tool; Engage+, a cross-channel marketing automation engine; and Insights+, an AI-powered analytics platform. By leveraging machine learning and real-time data processing, Capillary enables businesses to create seamless customer journeys across physical and digital touchpoints. The platform serves a diverse range of sectors, including retail, consumer packaged goods, and hospitality, helping organizations optimize customer lifetime value and drive sustainable growth through sophisticated reward structures and targeted communication strategies.

Recent filings

Filing Released Lang Actions
Revised Disclosure under Regulations 30 of the SEBI (LODR) Regulations, 2015.
Capital/Financing Update Classification · 95% confidence The document is a formal disclosure letter addressed to stock exchanges (BSE and NSE) regarding a board meeting decision to approve an investment for acquiring 100% shareholding in Session M Inc. It references compliance with SEBI Listing Regulations, specifically Regulation 30, which pertains to disclosure of material events. The content details the acquisition target, transaction nature, and other related information. There are no financial statements or detailed financial performance data presented, only an announcement of a corporate event (acquisition). The document length is about 5997 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Capital/Financing Update (CAP) since it announces a significant acquisition and investment decision affecting the company's capital structure and business operations.
2026-02-26 English
Clarification Regarding Exercise Price
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) providing clarification regarding the exercise price of stock options under the Capillary Employees Stock Option Scheme-2021. It references a Postal Ballot Notice dated February 6, 2026, and provides additional information in response to feedback from proxy advisors. The content focuses on clarifying details about a special resolution related to employee stock options, specifically the pricing mechanism and regulatory compliance. There is no financial data, earnings information, or detailed report content. The document is an announcement or clarification related to a shareholder vote and corporate governance matters, not a full report or financial statement. It is not a proxy solicitation or voting results announcement but a regulatory disclosure under SEBI Listing Obligations. Given the nature of the content and the regulatory context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2026-02-24 English
Updates
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a letter addressed to stock exchanges regarding a clarification on a Postal Ballot Notice dated February 6, 2026. It provides additional information about the exercise price related to a Special Resolution concerning the Capillary Employees Stock Option Scheme-2021. The letter references feedback from proxy advisors and clarifies the pricing mechanism for stock options. The content is focused on shareholder communication about a voting matter and does not contain financial statements or detailed financial results. It is not a full report but an announcement providing clarification related to a shareholder vote. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it relates to shareholder resolutions and voting information.
2026-02-24 English
Schedule of Analyst/Investors Meetings
Regulatory Filings Classification · 95% confidence The document is a formal disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the schedule of analysts and investors meetings to be attended by company officials. The content is an announcement of upcoming investor meetings, not a financial report or detailed presentation. The document length is short (2322 characters) and it does not contain financial data or detailed analysis. It is an update on investor relations activities, specifically the schedule of meetings, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2026-02-24 English
Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Investor Presentation Classification · 100% confidence The document is titled as an "Investor Presentation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015." It contains detailed information about the company's acquisition of Session M Inc., including business overview, growth strategy, M&A rationale, financial metrics like ARR, customer base, and market presence. The content is structured as a presentation with slides and graphics, focusing on financials, strategy, and market position. There is no indication that this is a regulatory announcement, earnings release, or a full annual or quarterly report. The document is clearly an investor presentation as per the subject line and content. Therefore, the appropriate classification is Investor Presentation (IP).
2026-02-24 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing the schedule of analysts and investor meetings. It references compliance with SEBI Listing Obligations Regulation 30, which pertains to disclosure requirements. The content is about informing the exchanges and public about upcoming investor meetings, explicitly stating no unpublished price sensitive information will be discussed. There are no financial statements, detailed financial data, or report attachments. The document is short (2322 characters) and serves as a regulatory announcement rather than a financial report or presentation. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2026-02-24 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.